Gallstone disease differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(3 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Gallstone disease}}
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Gallstone_disease]]
{{CMG}}; {{AE}} {{HM}}
{{CMG}}; {{AE}} {{HM}}


Line 17: Line 17:
<span style="font-size:85%">'''Abbreviations:'''
<span style="font-size:85%">'''Abbreviations:'''
'''[[RUQ]]'''= Right upper quadrant of the abdomen, '''LUQ'''= Left upper quadrant, '''LLQ'''= Left lower quadrant, '''RLQ'''= Right lower quadrant, '''LFT'''= [[Liver function test]], SIRS= [[Systemic inflammatory response syndrome]], '''[[ERCP]]'''= [[Endoscopic retrograde cholangiopancreatography]], '''IV'''= Intravenous, '''N'''= Normal, '''AMA'''= [[Antimitochondrial antibodies|Anti mitochondrial antibodies]], '''[[LDH]]'''= [[Lactate dehydrogenase]], '''GI'''= [[Gastrointestinal]], '''CXR'''= Chest X ray, '''IgA'''= [[Immunoglobulin A]], '''IgG'''= [[Immunoglobulin G]], '''IgM'''= [[Immunoglobulin M]], '''CT'''= [[Computed tomography]], '''[[PMN]]'''= Polymorphonuclear cells, '''[[ESR]]'''= [[Erythrocyte sedimentation rate]], '''[[CRP]]'''= [[C-reactive protein]], TS= [[Transferrin saturation]], SF= Serum [[Ferritin]], SMA= [[Superior mesenteric artery]], SMV= [[Superior mesenteric vein]], ECG= [[Electrocardiogram]]</span>
'''[[RUQ]]'''= Right upper quadrant of the abdomen, '''LUQ'''= Left upper quadrant, '''LLQ'''= Left lower quadrant, '''RLQ'''= Right lower quadrant, '''LFT'''= [[Liver function test]], SIRS= [[Systemic inflammatory response syndrome]], '''[[ERCP]]'''= [[Endoscopic retrograde cholangiopancreatography]], '''IV'''= Intravenous, '''N'''= Normal, '''AMA'''= [[Antimitochondrial antibodies|Anti mitochondrial antibodies]], '''[[LDH]]'''= [[Lactate dehydrogenase]], '''GI'''= [[Gastrointestinal]], '''CXR'''= Chest X ray, '''IgA'''= [[Immunoglobulin A]], '''IgG'''= [[Immunoglobulin G]], '''IgM'''= [[Immunoglobulin M]], '''CT'''= [[Computed tomography]], '''[[PMN]]'''= Polymorphonuclear cells, '''[[ESR]]'''= [[Erythrocyte sedimentation rate]], '''[[CRP]]'''= [[C-reactive protein]], TS= [[Transferrin saturation]], SF= Serum [[Ferritin]], SMA= [[Superior mesenteric artery]], SMV= [[Superior mesenteric vein]], ECG= [[Electrocardiogram]]</span>
<small>
{| align="center"
{| align="center"
|-
|-
Line 60: Line 61:
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Abnormal [[LFT]]
* Abnormal [[LFT]]
* WBC >10,000
* [[WBC]] >10,000
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound shows [[biliary]] dilatation/stents/tumor
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ultrasound]] shows [[biliary]] [[dilatation]]/[[stents]]/[[tumor]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Septic shock]] occurs with features of [[SIRS]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Septic shock]] occurs with features of [[SIRS]]
|-
|-
Line 77: Line 78:
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Abnormal [[LFT]]
* Abnormal [[LFT]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound shows [[biliary]] dilatation/stents/tumor
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ultrasound]] shows [[biliary]] [[dilatation]]/[[stents]]/[[tumor]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Biliary drainage ([[Endoscopic retrograde cholangiopancreatography|ERCP]]) + IV antibiotics
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Biliary]] drainage ([[Endoscopic retrograde cholangiopancreatography|ERCP]]) + IV [[antibiotics]]
|-
|-
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" | [[Acute cholecystitis|Acute cholecystitis]]
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" | [[Acute cholecystitis|Acute cholecystitis]]
Line 94: Line 95:
* [[Hyperbilirubinemia]]
* [[Hyperbilirubinemia]]
* [[Leukocytosis]]
* [[Leukocytosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound shows gallstone and evidence of inflammation
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ultrasound]] shows gallstone and evidence of [[inflammation]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Murphy's sign|Murphy’s sign]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Murphy's sign|Murphy’s sign]]
|-
|-
Line 111: Line 112:
* Increased [[amylase]] / [[lipase]]
* Increased [[amylase]] / [[lipase]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Ultrasound shows evidence of [[inflammation]]
* [[Ultrasound]] shows evidence of [[inflammation]]
* CT scan shows severity of [[pancreatitis]]
* [[CT scan]] shows severity of [[pancreatitis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Pain radiation to back
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Pain]] radiation to back
|-
|-
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Primary sclerosing cholangitis]]
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Primary sclerosing cholangitis]]
Line 127: Line 128:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Increased liver enzymes
* Increased [[liver enzymes]]
* Increased [[IgM]], [[IgG]]4
* Increased [[IgM]], [[IgG]]4
* [[Anti-neutrophil cytoplasmic antibody]] ([[p-ANCA]])
* [[Anti-neutrophil cytoplasmic antibody]] ([[p-ANCA]])
Line 133: Line 134:
* [[Anti-smooth muscle antibody]] (Anti-Sm)
* [[Anti-smooth muscle antibody]] (Anti-Sm)
* Anti-endothelial antibody
* Anti-endothelial antibody
* Anti-cardiolipin antibody
* [[Anticardiolipin antibody|Anti-cardiolipin antibody]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Endoscopic retrograde cholangiopancreatography|ERCP]] and [[Magnetic resonance cholangiopancreatography|MRCP]] shows  
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Endoscopic retrograde cholangiopancreatography|ERCP]] and [[Magnetic resonance cholangiopancreatography|MRCP]] shows  
* Multiple segmental [[strictures]]
* Multiple segmental [[strictures]]
* Mural irregularities
* Mural irregularities
* [[Biliary]] dilatation and diverticula
* [[Biliary]] [[dilatation]] and [[diverticula]]
* Distortion of [[biliary tree]]
* Distortion of [[biliary tree]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |The risk of [[cholangiocarcinoma]] in patients with [[primary sclerosing cholangitis]] is 400 times higher than the risk in the general population.
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |The risk of [[cholangiocarcinoma]] in patients with [[primary sclerosing cholangitis]] is 400 times higher than the risk in the general population.
Line 154: Line 155:
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Leukocytosis]]
* [[Leukocytosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound shows [[gallstone]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ultrasound]] shows [[gallstone]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Fatty food intolerance
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Fatty food intolerance
|-
|-
Line 170: Line 171:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Hyperactive/hypoactive
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Hyperactive/hypoactive
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* WBC> 10,000
* [[WBC]]> 10,000
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Air under [[diaphragm]] in upright [[CXR]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Air under [[diaphragm]] in upright [[CXR]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Hamman's sign]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Hamman's sign]]
Line 191: Line 192:
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[String sign]] on [[abdominal x-ray]] in [[Crohn's disease]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[String sign]] on [[abdominal x-ray]] in [[Crohn's disease]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
Extra intestinal findings:
Extra [[Intestine|intestinal]] findings:
* [[Uveitis]]
* [[Uveitis]]
* [[Arthritis]]
* [[Arthritis]]
Line 238: Line 239:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Abnormal LFTs
* Abnormal [[LFTs]]
* Viral serology
* [[Viral]] [[serology]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |USG
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Hepatitis|Hep A]]and [[Hepatitis|Hep E]] have fecoral route of transmission and [[Hepatitis|Hep B]] and [[Hepatitis|Hep C]] transmits via blood transfusion and sexual contact.
* [[Ultrasound]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Hepatitis|Hep A]]and [[Hepatitis|Hep E]] have fecoral route of transmission and [[Hepatitis|Hep B]] and [[Hepatitis|Hep C]] transmits via [[blood transfusion]] and [[sexual contact]].
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Liver mass|Liver masses]]
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Liver mass|Liver masses]]
Line 255: Line 257:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* CBC
* [[CBC]]
* LFTs
* [[LFTs]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |USG
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Ultrasound]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
Line 272: Line 275:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal/hypoactive
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal/hypoactive
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* CBC
* [[CBC]]
* Blood cultures
* [[Blood cultures]]
* Abnormal [[Liver function test|liver function tests]]
* Abnormal [[Liver function test|liver function tests]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* US
* [[Ultrasound]]
* CT
* [[CT]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
Line 297: Line 300:
* Abnormal [[Liver function test|liver function tests]]
* Abnormal [[Liver function test|liver function tests]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* US
* [[Ultrasound]]
* CT
* [[CT]]
* Liver biopsy
* [[Liver biopsy]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
Other symptoms:
Other symptoms:
Line 314: Line 317:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ±
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ±
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in liver failure leading to varices
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in [[liver failure]] leading to [[varices]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
Line 322: Line 325:
*Elevated [[Aspartate aminotransferase|serum aspartate aminotransferase]] and [[alanine aminotransferase]] levels may be more than five times the upper limit of the normal range.
*Elevated [[Aspartate aminotransferase|serum aspartate aminotransferase]] and [[alanine aminotransferase]] levels may be more than five times the upper limit of the normal range.
*Elevated serum [[alkaline phosphatase]] and [[Bilirubin|bilirubin levels]], decreased [[Albumin|serum albumin level]].
*Elevated serum [[alkaline phosphatase]] and [[Bilirubin|bilirubin levels]], decreased [[Albumin|serum albumin level]].
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
|-
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Findings on [[CT scan]] suggestive of [[Budd-Chiari syndrome]] include:
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Findings on [[CT scan]] suggestive of [[Budd-Chiari syndrome]] include:
*Early enhancement of the [[caudate lobe]] and [[central liver]] around the [[Inferior vena cavae|inferior vena cava]]
*Early enhancement of the [[caudate lobe]] and [[central liver]] around the [[Inferior vena cavae|inferior vena cava]]
Line 330: Line 330:
*Peripheral zones of the [[liver]] show reversed [[portal]] [[venous]] [[blood flow]]
*Peripheral zones of the [[liver]] show reversed [[portal]] [[venous]] [[blood flow]]
*In the [[chronic]] phase, there is [[caudate lobe]] enlargement and [[atrophy]] of the [[Liver|peripheral liver]] in affected areas
*In the [[chronic]] phase, there is [[caudate lobe]] enlargement and [[atrophy]] of the [[Liver|peripheral liver]] in affected areas
|}
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ascitic tap|Ascitic fluid examination]] shows:
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ascitic tap|Ascitic fluid examination]] shows:
*[[Total protein]] more than 2.5 g per deciliter
*[[Total protein]] more than 2.5 g per deciliter
Line 340: Line 339:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in cirrhotic patients
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in [[cirrhotic]] patients
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
Line 351: Line 350:


* Culture: Positive for single organism  
* Culture: Positive for single organism  
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound for evaluation of liver [[cirrhosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ultrasound]] for evaluation of [[liver cirrhosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
|-
|-
|}
|}
|}
|}
 
</small>
To review a differential diagnosis for abdominal pain, [[Abdominal pain differential diagnosis|click here]]
To review a differential diagnosis for abdominal pain, [[Abdominal pain differential diagnosis|click here]]


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WH}}
{{WS}}


[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Hepatology]]
[[Category:Hepatology]]
[[Category:Surgery]]
[[Category:Surgery]]
[[Category:Primary care]]
{{WH}}
{{WS}}

Latest revision as of 21:48, 29 July 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]

Overview

Gallstone disease must be differentiated from other diseases that cause right upper quadrant pain including gastroesophageal reflux disorder, peptic ulcer disease,hepatitis,sphincter of Oddi dysfunction,appendicitis, bile duct stricture, chronic pancreatitis, irritable bowel syndrome, ischemic heart disease, pyelonephritis, ureteral calculi and complications of gallstone disease include: acute cholecystitis, choledocholithiasis, acute pancreatitis, and acute cholangitis.

Differentiating Gallstone disease from other Diseases

  • Gallstone disease can manifest in a variety of clinical forms.
  • The presence of biliary colic is an important diagnostic feature to distinguish between gallstones and non-biliary stone disorders.
  • Patients who present with biliary colic are more likely to have gallstones detected on imaging. [1]
  • However, it is important to note that biliary colic can be concomitant in patients with other biliary disorders such as acute cholecystitis, choledocholithiasis, sphincter of Oddi dysfunction, and functional gallbladder disorder.[2][3]

Differential diagnosis

The differential diagnosis of diseases presenting with abdominal pain, fever and jaundice is discussed below.

Abbreviations: RUQ= Right upper quadrant of the abdomen, LUQ= Left upper quadrant, LLQ= Left lower quadrant, RLQ= Right lower quadrant, LFT= Liver function test, SIRS= Systemic inflammatory response syndrome, ERCP= Endoscopic retrograde cholangiopancreatography, IV= Intravenous, N= Normal, AMA= Anti mitochondrial antibodies, LDH= Lactate dehydrogenase, GI= Gastrointestinal, CXR= Chest X ray, IgA= Immunoglobulin A, IgG= Immunoglobulin G, IgM= Immunoglobulin M, CT= Computed tomography, PMN= Polymorphonuclear cells, ESR= Erythrocyte sedimentation rate, CRP= C-reactive protein, TS= Transferrin saturation, SF= Serum Ferritin, SMA= Superior mesenteric artery, SMV= Superior mesenteric vein, ECG= Electrocardiogram

Classification of pain in the abdomen based on etiology Disease Clinical manifestations Diagnosis Comments
Symptoms Signs
Abdominal Pain Fever Rigors and chills Jaundice Diarrhea GI Bleed Hypo-

tension

Guarding Rebound Tenderness Bowel sounds Lab Findings Imaging
Abdominal causes Inflammatory causes Pancreato-biliary disorders Acute suppurative cholangitis RUQ + + + + + + N Ultrasound shows biliary dilatation/stents/tumor Septic shock occurs with features of SIRS
Acute cholangitis RUQ + + N Ultrasound shows biliary dilatation/stents/tumor Biliary drainage (ERCP) + IV antibiotics
Acute cholecystitis RUQ + + Hypoactive Ultrasound shows gallstone and evidence of inflammation Murphy’s sign
Acute pancreatitis Epigastric + ± ± + + N Pain radiation to back
Primary sclerosing cholangitis RUQ + + N ERCP and MRCP shows The risk of cholangiocarcinoma in patients with primary sclerosing cholangitis is 400 times higher than the risk in the general population.
Cholelithiasis RUQ/Epigastric ± ± Normal to hyperactive for dislodged stone Ultrasound shows gallstone Fatty food intolerance
Gastric causes Gastrointestinal perforation Diffuse + ± ± +, depends on site + + ± Hyperactive/hypoactive Air under diaphragm in upright CXR Hamman's sign
Intestinal causes Inflammatory bowel disease Diffuse ± ± ± Hematochezia Normal/ Hyperactive String sign on abdominal x-ray in Crohn's disease

Extra intestinal findings:

Whipple's disease Diffuse ± ± + ± Normal Endoscopy is used to confirm diagnosis.

Images used to find complications

Extra intestinal findings:
Hepatic causes Viral hepatitis RUQ + + + in Hep A and Hep E + in fulminant hepatitis +in acute + Normal Hep Aand Hep E have fecoral route of transmission and Hep B and Hep C transmits via blood transfusion and sexual contact.
Liver masses RUQ + + in Liver abscess ± + in Hepatocellular carcinoma + in sepsis + in Liver abscess + in Liver abscess Normal
Liver abscess RUQ + + + ± - + + ± Normal/hypoactive
Hepatocellular carcinoma/Metastasis RUQ + - + - - - - -
  • Normal
  • Hyperactive if obstruction present

Other symptoms:

Budd-Chiari syndrome RUQ ± ± + in liver failure leading to varices Normal Findings on CT scan suggestive of Budd-Chiari syndrome include: Ascitic fluid examination shows:
Peritoneal causes Spontaneous bacterial peritonitis Diffuse + + + in cirrhotic patients + ± + + Hypoactive
  • Ascitic fluid PMN>250 cells/mm³
  • Culture: Positive for single organism
Ultrasound for evaluation of liver cirrhosis

To review a differential diagnosis for abdominal pain, click here

References

  1. Kraag N, Thijs C, Knipschild P (1995). "Dyspepsia--how noisy are gallstones? A meta-analysis of epidemiologic studies of biliary pain, dyspeptic symptoms, and food intolerance". Scand. J. Gastroenterol. 30 (5): 411–21. PMID 7638565.
  2. Portincasa P, Moschetta A, Palasciano G (2006). "Cholesterol gallstone disease". Lancet. 368 (9531): 230–9. doi:10.1016/S0140-6736(06)69044-2. PMID 16844493.
  3. Center SA (2009). "Diseases of the gallbladder and biliary tree". Vet. Clin. North Am. Small Anim. Pract. 39 (3): 543–98. doi:10.1016/j.cvsm.2009.01.004. PMID 19524793.

Template:WH Template:WS